The Internet of Medical Things market is expected to be worth $158.1 billion by 2022, but a few key challenges are standing in the way of its continued growth, according to a Deloitte report.
IoMT describes a system of internet-connected medical devices that can generate, collect, analyze and transmit data between each other, software applications and health systems. A few key benefits IoMT devices bring are improved drug management, patient outcomes and diagnoses, along with facilitating broadband-enabled healthcare services like remote patient monitoring.
Here are seven barriers inhibiting IoMT's adoption throughout the healthcare industry, according to Deloitte:
1. Outdated funding, business and operating models that might not be equipped to address emerging technological solutions.
2. To work effectively, IoMT solutions must be interoperable with one another, along with the various players — such as providers and payers — that are using the technologies.
3. As more medical devices become connected to one another and other systems, there's an increased risk for a data breaches or cyberattacks.
4. The regulatory landscape is still adjusting to emerging technologies, which IoMT vendors and developers must keep their eyes on.
5. A shortage of relevant digital talent among IT staff could affect an organization's ability to deploy IoMT tools.
6. Patients may not be comfortable with regular sharing of their health information, which means healthcare organizations and vendors must learn how to maintain trust in the digital age.
7. To fully realize the value of IoMT tools, healthcare organizations must scale them across their entire system to drive patient outcomes.
To download Deloitte's report, click here.